U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07949149) titled 'An Expanded Access Clinical Study of NR082 Ophthalmic Injection for the Treatment of ND4 Mutation-associated Leber Hereditary Optic Neuropathy (LHON).' on Nov. 13.
Brief Summary: This clinical study is an expanded access clinical study, aiming to explore the impact of different steroid administration regimens on the efficacy and safety in subjects with ND4 mutation-associated LHON treated bilaterally with NR082 ophthalmic injection.
Study Start Date: Aug. 31
Study Type: INTERVENTIONAL
Condition:
LHON
Intervention:
GENETIC: rAAV2-ND4
Bilateral intravitreal (IVT) injection at a dose of 1.0 x 10^10 vg (0.05 mL/eye/dose), adminis...